MD.(Queen's), M.Sc.(McMaster), FRCPC
Associate Professor, McMaster University
Department of Oncology — Division of Medical Oncology
Associate Chair, Education
P: 905-387-9711 Ext. 64602
Juravinski Cancer Centre
699 Concession Street
Hamilton Ontario, L8V 5C2
Areas of Interest
Dr. Dhesy-Thind's areas of interest include breast and gastrointestinal oncology trials, translational research, investigational new drug agents, and clinical practice guidelines
Pritchard,KI, Messersmith H, Elavathil L, Trudeau M, O’Malley F, Dhesy-Thind B. HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy J Clin Oncol 26(5) 2008
Dhesy-Thind SK, Pritchard KI, Messersmith H, O’Malley F, Elavathil L, Trudeau M. HER2/neu in systemic therapy for women with breast cancer: a systematic review. Breast Cancer Research and Treatment published online 17 July 2007.
Grunfeld E, Dhesy-Thind SK, Levine MN for the Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Follow-up after Treatment for Breast Cancer. CMAJ 172 (10); 2005.
Dhesy-Thind SK, Goffin JR, Cook RJ, Brouwers M, Reyno L, Major PP. Use of Bisphosphonates in Breast Cancer Metastatic to Bone: Compliance with Practice Guidelines. Current Oncology 9(1):7;2002.
Search for citations for Dr. Dhesy on PubMed